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Results: 
 
 
Figure 1. An example of a patient with large variation in 
bladder filling between planning CT (thin light green) and 
CBCT before a treatment fraction (thick light green). The 
planning-CT and CBCT are matched to bony anatomy. (Red 
=CTV, blue=PTV, dark green= rectum) 
The bladder volumes varied widely both within each patient 
(see example in Fig. 1), between patients in the same group 
and between the groups. 
The individual patient mean bladder volume varied from 
79±23 to 269±90 ml in group 1 and between 64±19 to 309±110 
ml in group 2. 
Furthermore, there was no difference in the group mean 
bladder volume between the groups, 138±82 ml in group 1 
and 150±92 ml in group 2 (p-value 0,59). 
 
Conclusion: The findings indicate that the use of a strict 
bladder protocol is not superior to a comfortably filled 
bladder-regime to ensure a consistent bladder volume 
throughout the whole treatment course. The conclusion 
would be to let the patient prepare according to his own 
preference with a comfortably filled bladder. This could 
result in an easier patient setup due to a more relaxed 
patient. The impact of the wide variations in bladder volume 
on toxicity and dose distribution is further to be determined. 
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Purpose or Objective: To compare patient-reported 
outcomes (PROs) with physician-assessed outcomes (PAOs) on 
gastrointestinal (GI) dysfunction pre- and post-radiotherapy 
(RT) for locally advanced prostate cancer. 
 
Material and Methods: Adverse GI effects were assessed in 
80 subjects treated with intensity-modulated RT for locally 
advanced prostate cancer (78 Gy/56 Gy in 39 fractions to the 
prostate/pelvic lymph nodes) in 2011-2012. A study-specific 
PRO and CTCAE.v.3-based PAOs were completed pre- and 
post-RT (end, 3, 6, 12, and 24 m). This study focuses on the 
18 (PROs) and 8 (PAOs) potentially RT-induced GI symptoms. 
Symptomatic subjects were considered as having PRO>Grade 
1 and PAO>Grade 0 symptom severity. Relative risk ratios 
(RR) with related 95% confidence intervals (95%CI), and p-
values (two-sided 5% significance level) were calculated for 
each symptom and follow-up time post-RT, with pre-RT 
symptom severity as the reference. 
 
Results: Across all follow-up times, significant RRs were 
observed for in total 4/18 (RR: 2-25; p<0.001-0.02) PROs and 
1/8 (RR: 2; p=0.0001-0.02) PAO (Table). Defecation urgency 
and Obstruction yielded the tightest 95%CI among the PROs, 
and Flatulence among the PAOs. The RR indicated that the 
PROs acknowledged both acute (12 symptoms) and late (3m: 
5; 6m: 4; 12m: 7; 24m: 9 symptoms) RT-induced effects, and 
that the PAOs typically focused on acute rather than late 
effects (7 vs. 1-3 symptoms). 
 
 
 
Conclusion: This study indicates that the number of 
symptoms and temporal patterns of RT-induced GI 
dysfunction in locally advanced prostate cancer depend on 
the applied assessment method. Physician-assessed outcomes 
according to CTCAE.v.3 captured acute effects, and in 
particular flatulence, whilst patient-reported outcomes 
captured both acute and late effects mainly related to 
defecation urgency and obstruction. 
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Purpose or Objective: The aim of this paper is to analyze, in 
prostate cancer patients treated with external beam 
radiotherapy (EBRT), the prognostic factors and their impact 
on the outcome in terms of Cancer Specific Overall Survival 
(CSOS), Biochemical Disease Free Survival (BDFS) and Clinical 
Disease Free Survival (CDFS). 
 
Material and Methods: From October 1999 and March 2012 
we treated by EBRT, 1080 prostate cancer patients. The 
mean age was 69.2 years. Pretreatment staging examinations 
were: digital rectal examination (DRE), pretreatment PSA 
(iPSA), abdominal ultrasound, abdominal CT scan and bone 
scan. The 87% of patients were classified as < cT2, 87% had a 
